<DOC>
	<DOC>NCT02660593</DOC>
	<brief_summary>MedlinePlus related topics: Blood Sugar Primary Outcome Measures: - Fast glucose and HbA1c change between the baseline and end of study [ Time Frame: From baseline to 30 and 100 days] - [ Designated as safety issue: No ] - Successful rate of blood glucose control (the proportion of patients with HbA1c &lt;7%) [ Time Frame: From baseline to 30 days and 100 days] [ Designated as safety issue: No ] Secondary Outcome Measures: â€¢ To evaluate the change of quality of life in the 1 months by the health questionnaire SF-36 [ Time Frame: From baseline to month 1 ] [ Designated as safety issue: No ]</brief_summary>
	<brief_title>Efficacy and Safety ofSanGrow Decoction for Patients With Diabetes</brief_title>
	<detailed_description>This study is aimed to evaluate the safety and efficacy of Sangrow Decotion, diet and exercise for the treatment of type 2 diabetes. Previous study has shown that this therapeutic regimen is safe and effective.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Type II diabetes mellitus patients who have received medical treatment for more than 3 months Patients willing to sign written informed consent form Patients unable or unwilling to comply with the requirements of the protocol Females who are pregnant or nursing or females of childbearing potential who are unwilling to maintain contraceptive therapy for the duration of the study Life expectancy &lt; 6 months due to concomitant illnesses.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Chinese medicine</keyword>
	<keyword>exercise</keyword>
	<keyword>diet</keyword>
</DOC>